Publications by authors named "Loredana Antal"
Article Synopsis
- Cancer patients are at a higher risk for severe COVID-19, and identifying specific biomarkers related to this risk could help target early treatment.
- A study analyzed plasma from 128 cancer patients with COVID-19 and found that lower levels of certain miRNAs (hsa-miR-150-5p and hsa-miR-93-5p) correlated with increased mortality, while hsa-miR-92b-3p linked to COVID-19 positivity.
- The research suggests that monitoring these miRNAs could serve as a potential blood biomarker for predicting COVID-19 severity in cancer patients, improving clinical outcomes.
